What they're doing is moving forward with the J&J process, which is at this point more official than the Boston Scientific process. Boston Scientific has not yet made an official offer for the company. They've merely proposed an offer.
J&J made a bid that was the minimum bid to be considered in the game. Now Boston is testing whether they need to go higher. I think they will if they need to, but if $68 is J&J's price, why pay more now?
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Got It!," you consent to our use of cookies.